ClinicalTrials.Veeva

Menu

Evaluation of the Safety and Tolerability of Exogenous Ketosis Induced by Free Beta-hydroxybutyrate.

I

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Status

Enrolling

Conditions

Exogenous Ketosis

Treatments

Dietary Supplement: Free Beta-hydroxybutyrate

Study type

Interventional

Funder types

Other

Identifiers

NCT05584371
UIE-4275-22-22-1

Details and patient eligibility

About

The goal of this clinical trial is to evaluate the safety and tolerability of free beta-hydroxybutyrate induced ketosis in healthy individuals. The main question it aims to answer is:

  • Is free beta-hydroxybutyrate safe and well tolerated by adults?

Participants will be asked to ingest 10 grams of beta-hydroxybutyrate, diluted in water and sweetened with Stevia, every morning between 9:00 and 11:00 for four weeks.

Full description

Several ketogenic interventions have shown benefits in a wide variety of clinical scenarios. Ketosis can be induced in different ways: by 72 hours of fasting, with a carbohydrate-restricted diet and with supplements. For emergency situations, such as heart failure, the first two options are not an option for patients as they cannot wait 72 hours.

There are 3 safe supplements for inducing ketosis: ketone salts, ketone esters and medium-chain triglycerides. Even though they all raise the beta-hydroxybutyrate serum concentration, they significantly differ in safety profiles, drug vehicles, palatability and monetary costs. A biologically identical beta-hydroxybutyrate supplement with prompt onset of action and free of salt, alcohol and drug vehicles would be an adequate option in many clinical settings.

A gender and age-balanced adult sample will be recruited in order to evaluate the safety and tolerability of free beta-hydroxybutyrate. Participants will be asked to ingest 10 grams of beta-hydroxybutyrate, diluted in water and sweetened with Stevia, every morning between 9:00 and 11:00 for four weeks. Symptoms will be evaluated on a daily basis with a self-administered opened questionnaire. A venous blood gas analysis will be made at the beginning, 2 and 4 weeks later.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Asymptomatic adults who have not been diagnosed with chronic degenerative diseases or diseases that cause acid-base imbalances.
  • Regarding women of childbearing age, it will only be recruited those who are using a method of contraception including oral contraception, contraceptive implant, contraceptive injection, intrauterine device (IUD) or patch.
  • Adults without cognitive impairment that can compromise decision making.

Exclusion criteria

  • Scheduled surgery during participation period.
  • Adults on a ketogenic diet, carbohydrate-restricted diet or intermittent fasting.
  • Women with a positive HCG serum or urine pregnancy test.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Exogenous ketosis
Experimental group
Description:
Intake of 10 grams of beta-hydroxybutyrate free of alcohol and salt.
Treatment:
Dietary Supplement: Free Beta-hydroxybutyrate

Trial contacts and locations

1

Loading...

Central trial contact

Lisa Pimentel, MD; Adrian Soto, PhD, MD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems